10x Genomics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
10x Genomics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q3 2024.
- 10x Genomics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 121M shares, a 2.55% increase year-over-year.
- 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 117M shares, a 2.9% increase from 2022.
- 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 114M shares, a 3.18% increase from 2021.
- 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 110M shares, a 9.09% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)